Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response

European Journal of Immunology

Volumn 29, Issue 1, 1999, Pages 81-89

  Lopes, Marcela F ^a   Nunes, Marise P ^b   Henriques Pons, Andrea ^b   Giese, Nathalia ^c   Morse III, Herbert C ^c   Davidson, Wendy F ^d,e   Araújo Jorge, Tania C ^b   DosReis, George A ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e AMERICAN RED CROSS   (United States)

Author keywords

Apoptosis; CD4+ T cell; Chagas' disease; Fas ligand; Trypanosoma cruzi

Indexed keywords

CD4 ANTIGEN; FAS LIGAND; INTERLEUKIN 10; INTERLEUKIN 4;

ANIMAL CELL; ARTICLE; CYTOTOXICITY; FEMALE; HELPER CELL; INFECTION SENSITIVITY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PARASITE IMMUNITY; PARASITEMIA; PRIORITY JOURNAL; T LYMPHOCYTE; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CHAGAS DISEASE; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DNA PRIMERS; FAS LIGAND PROTEIN; FEMALE; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PARASITEMIA; RNA, MESSENGER; TH2 CELLS; TRYPANOSOMA CRUZI;

EID: 0032921484     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199901)29:01<81::AID-IMMU81>3.0.CO;2-Y     Document Type: Article

References (40)

1. Van Parijs, L. and Abbas, A. K., Role of Fas-mediated cell death in the regulation of immune responses. Curr. Opin. Immunol. 1996. 8: 355-361.
2. Razvi, E. S. and Welsh, R. M., Programmed Cell Death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J. Virol. 1993. 67: 5754-5765.
3. + T cells from Human Immunodeficiency Virus-infected assymptomatic individuals. J. Exp. Med. 1992. 175: 331-340.
4. Meyaard, L., Otto, S. A., Jonker, R. R., Munster, M. J., Keet, R. P. M. and Miedema, F., Programmed death of T cells in HIV-1 infection. Science 1992. 257: 217-219.
5. Cifone, M. G., DeMaria, R., Roncaioli, P., Rippo, M. R., Azuma, M., Lanier, L. L., Santoni, A. and Testi, R., Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 1994. 177: 1547-1552.
6. Enari, M., Hug, H. and Nagata, S., Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 1995. 375: 78-81.
7. Suda, T., Takahashi, T., Golstein, P. and Nagata, S., Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993. 75: 1169-1178.
8. + T cell-mediated cytotoxicity. J. Immunol. 1994. 152: 1127-1133.
9. Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F. and Lynch, D. H., Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 1995. 181: 71-77.
10. Kirchhoff, L. V., American trypanosomiasis (Chagas' disease): a tropical disease now in the United States. N. Engl. J. Med. 1993. 329: 639-644.
11. Petry, K. and Eisen, H., Chagas disease: a model for the study of autoimmune diseases. Parasitol. Today 1989. 5: 111-116.
12. Gazzinelli, R. T., Oswald, I. P., Hieny, S., James, S. L. and Sher, A., The microbicidal activity of interferon-γ-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-β. Eur. J. Immunol. 1992. 22: 2501-2506.
13. DosReis, G. A., Cell-mediated immunity in experimental Trypanosoma cruzi infection. Parasitol. Today 1997. 13: 335-342.
14. + T cell death by apoptosis in experimental Chagas disease. J. Immunol. 1995. 154: 744-752.
15. DosReis, G. A., Fonseca, M. E. F. and Lopes, M. F., Programmed T cell death in experimental Chagas disease. Parasitol. Today 1995. 11: 390-394.
16. + T lymphocytes from infected hosts. J. Immunol. 1998. 160: 1313-1319.
17. Kayagaki, N., Yamaguchi, N., Nagao, F., Matsuo, S., Maeda, H., Okumura, K. and Yagita, H., Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. USA 1997. 94: 3914-3919.
18. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S., Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994. 76: 969-976.
19. Minoprio, P., Itohara, S., Heusser, C., Tonegawa, S. and Coutinho, A., Immunobiology of murine T. cruzi infection: the predominance of parasite-nonspecific responses and the activation of TCR I T cells. Immunol. Rev. 1989. 112: 184-206.
20. + T cell death by TCR; CD3 pathway and not by CD69 or Ly-6 activation pathway. Infect. Immun. 1996. 64: 1559-1564.
21. Davidson, W. F., Dumont, F. J., Bedigian, H. G., Fowlkes, B. J. and Morse, H. C., Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice. J. Immunol. 1986. 136: 4075-4084.
22. Hoft, D. F., Lynch, R. G. and Kirchhoff, L. V., Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi. J. Immunol. 1993. 151: 7038-7047.
23. Petray, P. B., Rottenberg, M. E., Bertot, G., Corral, R. S., Diaz, A., Orn, A. and Grinstein, S., Effect of anti-gamma-interferon and anti-interleukin-4 administration on the resistance of mice against infection with reticulotropic and myotropic strains of Trypanosoma cruzi. Immunol. Lett. 1993. 35: 77-80.
24. Hunter, C. A., Ellis-Neyes, L. A., Slifer, T., Kanaly, S., Grunig, G., Fort, M., Rennick, D. and Araújo, F. G., IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 1997. 158: 3311-3316.
25. Zhang, X., Brunner, T., Carter, L., Dutton, R. W., Rogers, P., Sato, T., Reed, J. C., Green, D. and Swain, S. L., Unequal death in T helper (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J. Exp. Med. 1997. 185: 1837-1849.
26. Varadhachary, A. S., Perdow, S. N., Hu, C., Ramanarayanan, M. and Salgame, P., Differential ability of T cell subsets to undergo activation-induced cell death. Proc. Natl. Acad. Sci. USA 1997. 94: 5778-5783.
27. Watanabe, N., Arase, H., Kurasawa, K., Iwamoto, I., Kayagaki, N., Yagita, H., Okumura, K., Miyatake, S. and Saito, T., Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death. Eur. J. Immunol. 1997. 27: 1858-1864.
28. Prud'Homme, G. J., Kono, D. H. and Theofilopoulos, A. N., Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-10 and interferon-gamma mRNA in the lymphnodes of lupus-prone mice. Mol. Immunol. 1995. 32: 495-503.
29. Reed, S. G., Brownell, C. E., Russo, D. M., Silva, J. S., Grabstein, K. H. and Morrissey, P. J., IL-10 mediates susceptibility to Trypanosoma cruzi infection. J. Immunol. 1994. 153: 3135-3140.
30. Fuss, I. J., Strober, W., Dale, J. K., Fritz, S., Pearlstein, G. R., Puck, J. M., Lenardo, M. J. and Straus, S. E., Characteristic T helper 2 T-cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity. J. Immunol. 1997. 158: 1912-1918.
31. Conceição-Silva, F., Hahne, M., Schröter, M., Louis, J. and Tschopp, J., The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity. Eur. J. Immunol. 1998. 28: 237-245.
32. Contreras, V. T., Salles, J. M., Thomas, N., Morel, C. M. and Goldenberg, S., In vitro differentiation of Trypanosoma cruzi under chemically defined conditions. Mol. Biochem. Parasitol. 1985. 16: 315-327.
33. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 1993. 177: 195-200.
34. Leo, O., Foo, M., Sachs, D. H., Samelson, L. H. and Bluestone, J. A., Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 1987. 84: 1374-1377.
35. Kubo, R. T., Born, W., Kappler, J. W., Marrack, P. and Pigeon, M., Characterization of a monoclonal antibody which detects all murine α/β T cell receptors. J. Immunol. 1989. 142: 2736-2742.
36. De Souza, W., Cell biology of Trypanosoma cruzi. Intern. Rev. Cytol. 1984. 86: 197-283.
37. Watanabe-Fukunaga, R., Brannan, C. I., ltoh, N., Yonehara, S., Copeland, N. G., Jenkins, N. A. and Nagata, S., The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 1992. 148: 1274-1279.
38. Gazzinelli, R. T., Eltoum, I., Wynn, T. A. and Sher, A., Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 1993. 151: 3672-3681.
39. Yang, Y., Mércep, M., Ware, C. F. and Ashwell, J. D., Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 1995. 181: 1673-1682.
40. Pont, S., Naquet, P., Marchetto, S., Regnier-Vigouroux, A., Blanc, D., Pierres, A. and Pierres, M., Identification of 5 topographic domains of the mouse LFA-1 molecule: subunit assignment and functional involvement in lymphoid cell interactions. J. Immunol. 1986. 136: 3750-3759.